Nutex Health Files 8-K on Financials
Ticker: NUTX · Form: 8-K · Filed: Mar 28, 2024 · CIK: 1479681
Sentiment: neutral
Topics: financial-reporting, 8-K, company-history
Related Tickers: NUTX
TL;DR
NUTX filed an 8-K on 3/28/24 detailing financial results.
AI Summary
Nutex Health, Inc. filed an 8-K on March 28, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
Why It Matters
This filing provides investors with updated financial information and operational results for Nutex Health, Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not inherently introduce new risks.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- Clinigence Holdings, Inc. (company) — Former Company Name
- iGambit, Inc. (company) — Former Company Name
- March 28, 2024 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K filing for Nutex Health, Inc.?
The primary purpose is to report on the Results of Operations and Financial Condition of Nutex Health, Inc., and it includes Financial Statements and Exhibits.
When was this 8-K filed with the SEC?
This 8-K was filed on March 28, 2024.
What were Nutex Health, Inc.'s previous names?
Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
Where is Nutex Health, Inc. headquartered?
Nutex Health, Inc. is headquartered at 6030 S. Rice Ave., Suite C, Houston, Texas 77081.
What is the Commission File Number for Nutex Health, Inc.?
The Commission File Number for Nutex Health, Inc. is 001-41346.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-03-28 17:27:13
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value NUTX The NASDAQ Stock Mar
Filing Documents
- nutx-20240328x8k.htm (8-K) — 29KB
- nutx-20240328xex99.htm (EX-99) — 476KB
- nutx-20240328xex99001.jpg (GRAPHIC) — 4KB
- 0001558370-24-004285.txt ( ) — 660KB
- nutx-20240328.xsd (EX-101.SCH) — 4KB
- nutx-20240328_def.xml (EX-101.DEF) — 3KB
- nutx-20240328_lab.xml (EX-101.LAB) — 17KB
- nutx-20240328_pre.xml (EX-101.PRE) — 11KB
- nutx-20240328x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On March 28, 2024, Nutex Health Inc. (the "Company") announced its financial and operating results for the quarter ending December 31, 2023. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release dated March 28, 2024 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. THE INFORMATION CONTAINED IN ITEM 2.02 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED "FILED" FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION STATEMENT OR OTHER FILING PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, EXCEPT AS OTHERWISE EXPRESSLY STATED IN SUCH FILING SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 28, 2024 Nutex Health Inc. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer